AFFINIA THERAPEUTICS INC.
Profile
Company Names
AFFINIA THERAPEUTICS INC.
TDTX INC.
Addresses
43 FOUNDRY AVE, SUITE 120, WALTHAM, MA 02453
C/O AFFINIA THERAPEUTICS INC., 43 FOUNDRY AVE, SUITE 120, WALTHAM, MA 02453
C/O AFFINIA THERAPEUTICS INC., 100 BEAVER STREET, WALTHAM, MA 02453
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA 02142
Phone Numbers
617-430-7817
Entity Type:
CORPORATION
Industry:
OTHER
Year Incorporated:
2019
State Incorporated:
DELAWARE
Total Amount Raised:
$170,141,232.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-09-16
$13,268,335.00
$45,000,000.00
$31,731,665.00
Equity
3
2021-04-20
$109,999,955.00
$109,999,955.00
$0.00
Equity
2
2020-03-12
$38,522,942.00
$68,522,920.00
$29,999,978.00
Equity
1
2019-10-22
$8,350,000.00
$8,350,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID
GRAYZEL
DIRECTOR
ANNOVATION BIOPHARMA, INC.
| ARTEAUS THERAPEUTICS, LLC
| ATLAS VENTURE FUND XI, L.P.
| AKRIVEIA THERAPEUTICS, LLC
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| AFFINIA THERAPEUTICS INC.
| ATLAS VENTURE FUND XII, L.P.
| AEROVATE THERAPEUTICS, INC.
| XILIO THERAPEUTICS, INC.
| SANTI THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| TRIANA BIOMEDICINES, INC.
| ATLAS VENTURE FUND XIII, L.P.
| COMANCHE BIOPHARMA CORP.
| ATLAS VENTURE FUND XIV, L.P.
ROBERT
JOHNSON
EXECUTIVE OFFICER
INTELLIGENT BEAUTY INC.
| BELLATRIX EXPLORATION LTD.
| IB HOLDING, LLC
| 24M TECHNOLOGIES, INC.
| DRAGONTECH INTERNATIONAL, LLC
| ALTUS REALTY INCOME FUND II, LLC
| AFFINIA THERAPEUTICS INC.
| N3RD STREET GAMERS, LLC
| LENDINGHOME FUNDING VEHICLE, LLC
| VIASAT INC
| YOUME HEALTHCARE, INC.
| STUMPTOWN CAPITAL FUND LLC
| EIKONOKLASTES THERAPEUTICS, INC.
| MICHIGAN STATE UNIVERSITY FEDERAL CREDIT UNION
EDWARD
MATHERS
DIRECTOR
RA PHARMACEUTICALS, INC.
| RHYTHM PHARMACEUTICALS, INC.
| SATORI PHARMACEUTICALS INC
| MIRNA THERAPEUTICS, INC.
| RHYTHM HOLDING COMPANY, LLC
| LUMENA PHARMACEUTICALS, INC.
| LUMOS PHARMA, INC.
| AMPLYX PHARMACEUTICALS, INC.
| LIQUIDIA TECHNOLOGIES INC
| INOZYME PHARMA, INC.
| SYNLOGIC, INC.
| AFFINIA THERAPEUTICS INC.
| CODE BIOTHERAPEUTICS, INC.
| TREVI THERAPEUTICS, INC.
| SORRISO PHARMACEUTICALS, INC.
| MBX BIOSCIENCES, INC.
| CARDURION PHARMACEUTICALS, INC.
| BRENIG THERAPEUTICS, INC.
| SENTI BIOSCIENCES, INC.
| SENTI BIOSCIENCES HOLDINGS, INC.
| SENTI HOLDINGS, INC.
| SENTI BIOSCIENCES, INC.
ROB
MAY
EXECUTIVE OFFICER
CAROLINE
STOUT
DIRECTOR
ROBERT
WEISSKOFF
DIRECTOR
TETRAPHASE PHARMACEUTICALS INC
| ACCURI CYTOMETERS INC
| TRANSAVE INC
| IKANO THERAPEUTICS INC.
| ACORN CARDIOVASCULAR INC
| VIEWRAY INC
| BIOCONNECT SYSTEMS INC
| AMPHORA MEDICAL, INC.
| CARIBOU BIOSCIENCES, INC.
| IOWA APPROACH, INC.
| ZENFLOW, INC.
| TEMPEST THERAPEUTICS, INC.
| FARAPULSE, INC.
| CHECKMATE PHARMACEUTICALS, INC.
| AFFINIA THERAPEUTICS INC.
| XILIO THERAPEUTICS, INC.
| RARECYTE, INC.
| SHOUTI INC.
| BASECAMP BIO INC.
| ADELA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2025-09-16
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
